• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

阻塞性睡眠呼吸暂停(OSA)患者队列中选择性miRNA-基因靶点的计算机模拟研究及其验证研究

In-silico investigations of selective miRNA-gene targets and their validation studies in obstructive sleep apnea (OSA) patient cohorts.

作者信息

Khurana Sartaj, Waidha Kamran, Guleria Randeep, Sharda Shivani, Bose Sudeep

机构信息

Amity Institute of Biotechnology, Amity University, Noida, Uttar Pradesh, India; Amity Institute of Molecular Medicine and Stem Cell Research, Amity University, Noida, Uttar Pradesh, India.

Amity Institute of Biotechnology, Amity University, Noida, Uttar Pradesh, India.

出版信息

Comput Biol Chem. 2020 Apr 18;87:107264. doi: 10.1016/j.compbiolchem.2020.107264.

DOI:10.1016/j.compbiolchem.2020.107264
PMID:32447199
Abstract

BACKGROUND

Obstructive sleep apnoea (OSA) is a prevalent form of sleep disordered breathing which results in sleep fragmentation and deprivation. Obesity and cardiovascular disorders are the major risk factors associated with OSA. Molecular analysis of the factors associated with OSA could demarcate the clinical analysis pattern in a population.

OBJECTIVE

This study pertains to in-silico analyses of miRNA and their gene targets with validation for their potential role in OSA as putative biomarker candidates.

METHODS

miRDB, TargetScan and miRanda databases were used to identify targets of miR-27 and let-7 that have documented role in OSA and co-related obesity and cardiovascular disorders. Quantitative PCR was used to analyze expression pattern of miR-27 and let-7 in obese and non-obese OSA patient cohorts with respective controls. In-silico analysis was done using PatchDoc to obtain atomic contact energy (ACE) scores that indicated the docked gene targets to the predicted miRNA structures. The docked structures were analysed using Maestro Suite 11 for the hydrogen and aromatic interactions.

RESULTS

Downregulation of miR-27 and let-7 in OSA compared to controls was observed. In-silico data analysis was performed for gene targets (TGFBR1, TGFBR2, SMAD2, SMAD4, CRY2 and CNR1) of the selected miRNAs (miR-27 and let-7). Among all, CNR1 and CRY2 were found to be better targets for miR-27 and let-7 respectively as per ACE scores, ROC scores and expression fold change in OSA.

CONCLUSION

Our study gives insights to the expression profiling of miR-27 and let-7 and explore a set of potential target genes (CNR1 and CRY2) of these two miRNAs for a promising clinical relevance in OSA.

摘要

背景

阻塞性睡眠呼吸暂停(OSA)是睡眠呼吸障碍的一种常见形式,会导致睡眠片段化和剥夺。肥胖和心血管疾病是与OSA相关的主要危险因素。对与OSA相关因素的分子分析可以划定人群中的临床分析模式。

目的

本研究涉及对miRNA及其基因靶点的计算机分析,并验证它们在OSA中作为假定生物标志物候选物的潜在作用。

方法

使用miRDB、TargetScan和miRanda数据库来识别在OSA以及相关的肥胖和心血管疾病中起作用的miR-27和let-7的靶点。采用定量PCR分析肥胖和非肥胖OSA患者队列及其各自对照中miR-27和let-7的表达模式。使用PatchDoc进行计算机分析以获得原子接触能量(ACE)分数,该分数表明对接的基因靶点与预测的miRNA结构。使用Maestro Suite 11分析对接结构的氢和芳香族相互作用。

结果

与对照组相比,观察到OSA中miR-27和let-7的表达下调。对所选miRNA(miR-27和let-7)的基因靶点(TGFBR1、TGFBR2、SMAD2、SMAD4、CRY2和CNR1)进行了计算机数据分析。根据ACE分数、ROC分数和OSA中的表达倍数变化,发现CNR1和CRY2分别是miR-27和let-7的更好靶点。

结论

我们的研究深入了解了miR-27和let-7的表达谱,并探索了这两种miRNA的一组潜在靶基因(CNR1和CRY2)在OSA中的临床应用前景。

相似文献

1
In-silico investigations of selective miRNA-gene targets and their validation studies in obstructive sleep apnea (OSA) patient cohorts.阻塞性睡眠呼吸暂停(OSA)患者队列中选择性miRNA-基因靶点的计算机模拟研究及其验证研究
Comput Biol Chem. 2020 Apr 18;87:107264. doi: 10.1016/j.compbiolchem.2020.107264.
2
Drug therapy for obstructive sleep apnoea in adults.成人阻塞性睡眠呼吸暂停的药物治疗
Cochrane Database Syst Rev. 2013 May 31;2013(5):CD003002. doi: 10.1002/14651858.CD003002.pub3.
3
Effects of opioid, hypnotic and sedating medications on sleep-disordered breathing in adults with obstructive sleep apnoea.阿片类、催眠和镇静药物对阻塞性睡眠呼吸暂停成年患者睡眠呼吸障碍的影响。
Cochrane Database Syst Rev. 2015 Jul 14(7):CD011090. doi: 10.1002/14651858.CD011090.pub2.
4
Drug therapy for obstructive sleep apnoea in adults.成人阻塞性睡眠呼吸暂停的药物治疗
Cochrane Database Syst Rev. 2006 Apr 19(2):CD003002. doi: 10.1002/14651858.CD003002.pub2.
5
Educational, supportive and behavioural interventions to improve usage of continuous positive airway pressure machines in adults with obstructive sleep apnoea.旨在提高阻塞性睡眠呼吸暂停成年患者持续气道正压通气机使用情况的教育、支持和行为干预措施。
Cochrane Database Syst Rev. 2014 Jan 8(1):CD007736. doi: 10.1002/14651858.CD007736.pub2.
6
Prescription of Controlled Substances: Benefits and Risks管制药品的处方:益处与风险
7
Multilevel-Single Stage-Functional Rhinoplasty & BRP (Barb Reposition Palatoplasty) in Surgical Management of Primary Snorers, UARS and Mild OSA.多级单阶段功能性鼻整形术及BRP(倒刺复位腭成形术)在原发性打鼾者、上气道阻力综合征及轻度阻塞性睡眠呼吸暂停手术治疗中的应用
Indian J Otolaryngol Head Neck Surg. 2024 Dec;76(6):5672-5681. doi: 10.1007/s12070-024-05059-y. Epub 2024 Oct 8.
8
An Objective Study to Establish Incidence of True Obstructive Sleep Apnoea (OSA) in Sleep Disordered Breathing in the Paediatric Age Group and Assessment of Benefit of Surgery (Tonsillectomy and Adenoidectomy) in Non Responders to Medical Treatment in Mild OSA.一项关于确定小儿年龄组睡眠呼吸障碍中真性阻塞性睡眠呼吸暂停(OSA)发病率以及评估轻度OSA中对药物治疗无反应者手术(扁桃体切除术和腺样体切除术)获益情况的客观研究。
Indian J Otolaryngol Head Neck Surg. 2024 Oct;76(5):4189-4199. doi: 10.1007/s12070-024-04813-6. Epub 2024 Jun 25.
9
Clinical utility of limited channel sleep studies versus polysomnography for obstructive sleep apnoea.有限通道睡眠研究与多导睡眠图在阻塞性睡眠呼吸暂停诊断中的临床效用比较
Cochrane Database Syst Rev. 2025 May 6;5(5):CD013810. doi: 10.1002/14651858.CD013810.pub2.
10
Practice parameters for the surgical modifications of the upper airway for obstructive sleep apnea in adults.成人阻塞性睡眠呼吸暂停上气道手术矫正的实践参数。
Sleep. 2010 Oct;33(10):1408-13. doi: 10.1093/sleep/33.10.1408.

引用本文的文献

1
Integrative analysis of candidate MicroRNAs and gene targets for OSA management using in silico and in-vitro approach.使用计算机模拟和体外方法对阻塞性睡眠呼吸暂停管理的候选微小RNA和基因靶点进行综合分析。
Biotechnol Notes. 2025 Jan 28;6:79-88. doi: 10.1016/j.biotno.2025.01.003. eCollection 2025.
2
Identification biomarkers in disease progression of obstructive sleep apnea from children serum based on WGCNA and Mfuzz.基于加权基因共表达网络分析(WGCNA)和Mfuzz算法从儿童血清中鉴定阻塞性睡眠呼吸暂停疾病进展中的生物标志物
Front Neurol. 2024 Oct 1;15:1452507. doi: 10.3389/fneur.2024.1452507. eCollection 2024.
3
The advent of RNA-based therapeutics for metabolic syndrome and associated conditions: a comprehensive review of the literature.
基于 RNA 的代谢综合征及相关疾病治疗药物的出现:文献综述
Mol Biol Rep. 2024 Apr 5;51(1):493. doi: 10.1007/s11033-024-09457-x.
4
The role of microRNAs in pathophysiology and diagnostics of metabolic complications in obstructive sleep apnea patients.微小RNA在阻塞性睡眠呼吸暂停患者代谢并发症的病理生理学及诊断中的作用
Front Mol Neurosci. 2023 Jul 21;16:1208886. doi: 10.3389/fnmol.2023.1208886. eCollection 2023.
5
Design and identification of novel annomontine analogues against SARS-CoV-2: An approach.
Heliyon. 2021 Apr;7(4):e06657. doi: 10.1016/j.heliyon.2021.e06657. Epub 2021 Apr 2.
6
MicroRNA: A Key Player for the Interplay of Circadian Rhythm Abnormalities, Sleep Disorders and Neurodegenerative Diseases.微小RNA:昼夜节律异常、睡眠障碍与神经退行性疾病相互作用的关键因素
Clocks Sleep. 2020 Jul 23;2(3):282-307. doi: 10.3390/clockssleep2030022. eCollection 2020 Sep.